About Hospital Universitari Arnau de Vilanova
El Hospital Universitario Arnau de Vilanova es el centro hospitalario de referencia de la sanidad pública de la provincia de Lérida, del Alto Pirineo y Arán y de algunas comarcas de la Franja de Aragón. Su gestión corresponde al Instituto Catalán de la Salud. Actualmente dispone de 463 camas.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
PETHEMA Foundation
14
Hoffmann-La Roche
12
MedSIR
10
SOLTI Breast Cancer Research Group
10
Pfizer
8
Spanish Breast Cancer Research Group
8
Sociedad Española de Neumología y Cirugía Torácica
7
Eli Lilly and Company
6
Genentech, Inc.
6
Grupo Espanol Multidisciplinario del Cancer Digestivo
6
Hospital Universitari Vall d'Hebron Research Institute
6
Clinical Trials at Hospital Universitari Arnau de Vilanova
During the past decade, Hospital Universitari Arnau de Vilanova conducted 137 clinical trials. In the 10-year time frame, 137 clinical trials started and 55 clinical trials were completed, i.e. on
average, 40.1% percent of trials that started reached the finish line to date. In the past 5 years, 65 clinical trials started and 29 clinical trials were completed. i.e. 44.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer
2004-02-01
2019-04-04
Completed
1,384
Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients
2006-01-01
2017-02-17
Completed
876
Usefulness of Microbiological Tests in Community-Acquired Pneumonia
2006-04-01
2008-05-01
Unknown status
250
Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily
2004-11-01
2007-03-01
Completed
99
ICTUS Study: International Citicoline Trial on Acute Stroke
2006-10-01
2012-03-01
Terminated
2,298
Efficacy Study of the Addition of Bemiparin to Icodextrin Solution in Peritoneal Dialysis Patients (Bemidextrina)
2006-09-01
2009-05-01
Completed
76
Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia
2003-07-01
2007-12-01
Completed
360
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Universitari Arnau de Vilanova" #1 sponsor was "PETHEMA Foundation" with 14 trials, followed by "Hoffmann-La Roche" with 12 trials
sponsored, "MedSIR" with 10 trials sponsored, "SOLTI Breast Cancer Research Group" with 10 trials sponsored and "Pfizer"
with 10 trials sponsored. Other sponsors include 182 different institutions and
companies that sponsored additional 118 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari Arnau de Vilanova"
#1 collaborator was "Pfizer" with 8 trials as a collaborator, "Hoffmann-La Roche" with 7 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Breast International Group" with 5 trials as a collaborator and "Merck Sharp & Dohme LLC" with 5 trials as a collaborator. Other collaborators include 132 different institutions and companies that were
collaborators in the rest 117 trials.
Clinical Trials Conditions at Hospital Universitari Arnau de Vilanova
According to Clinical.Site data, the most researched conditions in "Hospital Universitari Arnau de Vilanova" are
"Breast Cancer" (36 trials), "Metastatic Breast Cancer" (16 trials), "Breast Neoplasms" (9 trials), "Multiple Sclerosis" (6 trials) and "Triple Negative Breast Cancer" (6 trials). Many other conditions were trialed in "Hospital Universitari Arnau de Vilanova" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitari Arnau de Vilanova
Most popular intervention types in "Hospital Universitari Arnau de Vilanova" are "Drug" (176 trials), "Other" (32 trials), "Procedure" (15 trials), "Device" (13 trials) and "Biological" (11 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (37 trials), "Trastuzumab" (15 trials), "Paclitaxel" (12 trials), "Capecitabine" (11 trials) and "Docetaxel" (9 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitari Arnau de Vilanova
The vast majority of trials in "Hospital Universitari Arnau de Vilanova" are
190 trials for "All" genders, 48 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Hospital Universitari Arnau de Vilanova
Currently, there are NaN active trials in "Hospital Universitari Arnau de Vilanova".
2 are not yet recruiting,
48 are recruiting,
24 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 126 completed trials in Hospital Universitari Arnau de Vilanova,
2 suspended trials,
and 23 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitari Arnau de Vilanova, 14 "Phase 1"
clinical trials were conducted, 59 "Phase 2" clinical
trials and 84 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 20 trials, and there were
also 26 trials that are defined as “Not Applicable".
Departments of Hospital Universitari Arnau de Vilanova
Hospital Universitari Arnau de Vilanova has several departments that took part in Clinical trials: "Hospital Universitari Arnau de Vilanova de Lleida; Servicio de Neurología" - 4 trials, "Hospital Universitario Arnau de Vilanova, Servicio de Oncologia" - 2 trials
Departments List